Clinical Trials Directory

Trials / Completed

CompletedNCT00690105

Protopic Ointment in Adult Atopic Eczema of the Face

Comparative, Multicentre, Randomized, Double-blind Study to Assess the Efficacy of Tacrolimus 0.1% Ointment Versus Fluticasone 0.005% Ointment in Adult Patients Suffering From Moderate to Severe Atopic Dermatitis and Presenting With So-called 'Red Face' Lesions of the Head and Neck.

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
577 (actual)
Sponsor
Astellas Pharma Inc · Industry
Sex
All
Age
16 Years
Healthy volunteers
Not accepted

Summary

Patients with facial atopic eczema and a poor response to topical corticosteroid applied either Protopic or Fluticasone ointment twice a day for 3 weeks. They could continue during 3 more weeks once a day if needed or change for the other ointment.

Detailed description

Treatments were to be applied twice daily over all lesions on the face (except for the eyelids) until clearance, for a maximum of 3 weeks and then, in case of uncleared residual lesions, once daily for up to 3 further weeks. In the event of a flare-up the treatment was to be resumed twice a day until the end of the study.

Conditions

Interventions

TypeNameDescription
DRUGtacrolimus 0.1%ointment
DRUGfluticasone 0.005 %ointment

Timeline

Start date
2004-02-01
Primary completion
2005-07-01
Completion
2005-07-01
First posted
2008-06-04
Last updated
2014-09-01

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT00690105. Inclusion in this directory is not an endorsement.